Genotypic resistance testing improves antiretroviral treatment outcomes in a cohort of adolescents in Cameroon: Implications in the dolutegravir-era.
Pabo WLRT, Njume D, Ndip RN, Takou D, Santoro MM, Chenwi C, Beloumou G, Semengue ENJ, Nka AD, Ka'e AC, Teto G, Dambaya B, Djupsa S, Nyasa RB, Anguechia DHG, Kamta C, Bala L, Lambo V, Sosso SM, Colizzi V, Perno CF, Fokam J, Ndjolo A.
Pabo WLRT, et al. Among authors: ndip rn.
J Public Health Afr. 2023 Oct 1;14(10):2612. doi: 10.4081/jphia.2023.2612. eCollection 2023 Oct 31.
J Public Health Afr. 2023.
PMID: 38020274
Free PMC article.